GALNT13-AS1: A Potential Drug Target and Biomarker (G100144595)

Target Name: GALNT13-AS1

NCBI ID: G100144595

GALNT13-AS1

Other Name(s): GALNT13 antisense RNA 1

GALNT13-AS1: A Potential Drug Target and Biomarker

GALNT13-AS1 is a gene that encodes a protein known as GALNT13-AS1. GALNT13-AS1 is a non-coding RNA molecule that has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. It is a potential drug target and biomarker that can betargeted by small molecules to inhibit its activity and treat various diseases.

GALNT13-AS1 is a member of the GALNT family of non-coding RNAs, which are known to play a crucial role in the regulation of gene expression. The GALNT family consists of four RNA molecules: GALNT1, GALNT2, GALNT3, and GALNT4. GALNT13-AS1 is a splicing alternative of the GALNT1 gene.

GALNT13-AS1 has been shown to be involved in cell adhesion and migration. GALNT13-AS1 has been shown to regulate the activity of the protein N-cadherin, which is a transmembrane protein that plays a role in cell-cell adhesion. N-cadherin is a target for many diseases, including cancer, neurodegenerative diseases, and developmental disorders. Therefore, GALNT13-AS1 may be a potential drug target for these diseases.

In addition to its role in cell adhesion and migration, GALNT13-AS1 has also been shown to be involved in the regulation of cell proliferation. GALNT13-AS1 has been shown to regulate the activity of the protein p21, which is a T-cell factor that plays a role in cell proliferation. p21 is a target for many diseases, including cancer, and Therefore, GALNT13-AS1 may be a potential biomarker for cancer.

GALNT13-AS1 has also been shown to be involved in the regulation of inflammation. GALNT13-AS1 has been shown to regulate the activity of the protein NF-kappa-B, which is a transcription factor that plays a role in inflammation. NF-kappa-B is a target for many diseases, including cancer, autoimmune diseases, and neuroinflammatory diseases. Therefore, GALNT13-AS1 may be a potential drug target for these diseases.

GALNT13-AS1 is a non-coding RNA molecule that has been shown to play a role in various cellular processes. It may be a potential drug target and biomarker for many diseases. Many small molecules have been shown to interact with GALNT13-AS1 and to inhibit its activity. Therefore, GALNT13-AS1 may be a promising target for drug development.

In conclusion, GALNT13-AS1 is a non-coding RNA molecule that has been shown to play a role in various cellular processes. It may be a potential drug target and biomarker for many diseases. Many small molecules have been shown to interact with GALNT13-AS1 and to inhibit its activity. Further research is needed to fully understand the role of GALNT13-AS1 in disease and to develop effective treatments.

Protein Name: GALNT13 Antisense RNA 1

The "GALNT13-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GALNT13-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets